The board shall place a substance in schedule V if it finds that:
1. The substance has low potential for abuse relative to the controlled substances listed in schedule IV;
2. The substance has currently accepted medical use in treatment in the United States; and 3. The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed in schedule IV.